TAE Life Sciences appoints Dr. Dee Khuntia to its Board of Directors

– USA, CA –  TAE Life Sciences, a pioneer in advancing Boron Neutron Capture Therapy for cancer treatment, announced the appointment of Dr. Dee Khuntia (M.D., FASTRO) to its Board of Directors, brings unparalleled expertise and invaluable insights to the board, further strengthening TAE Life Sciences’ position as a pioneer in the field of radiation oncology.

About Dr. Deepak Khuntia

As SVP of Medical Affairs and CMO at Varian, a Siemens Healthineers Company, Dr. Dee Khuntia has been instrumental in revolutionizing cancer treatment and advancing cardiac radiosurgery technologies worldwide. With a distinguished career spanning decades, Dr. Khuntia has established himself as one of the foremost authorities in radiation oncology, particularly in the treatment of brain tumors, head and neck cancer, and lung cancer.

Dr. Dee Khuntia said, “I believe in the promising future of Boron Neutron Capture Therapy and its potential to transform the landscape of radiation oncology. I look forward to working closely with the board and management team to drive advancements in cancer care and improve patient outcomes.”

About TAE Life Sciences

TAE Life Sciences is a privately held biotechnology company committed to developing a new biologically targeted radiation therapy based on Boron Neutron Capture Therapy. TAE Life Sciences is the only company developing the next-generation targeted boron drugs and low-energy accelerator-based neutron system optimized for an in-hospital BNCT program that delivers cancer-killing radiation with cellular-level precision to treat patients with aggressive and refractory cancers. TAE Life Sciences’ Alphabeam BNCT system and proprietary boronated drugs are still in the investigational stage, and not available commercially.

SOURCE: https://taelifesciences.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.